2018
DOI: 10.3389/fncel.2018.00178
|View full text |Cite
|
Sign up to set email alerts
|

mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis

Abstract: A pathological hallmark of multiple sclerosis (MS) is myelin loss in brain white matter accompanied by compromised remyelination. Demyelinated lesions are deeply associated with oligodendrocyte apoptosis and a robust inflammatory response. Although various studies point towards a noxious role of inflammation in MS, others emphasize a positive role for the innate immune cells in disease progression. A cytokine well-known to stimulate cell survival, proliferation and differentiation of myeloid cells, macrophage … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
44
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

4
6

Authors

Journals

citations
Cited by 45 publications
(46 citation statements)
references
References 70 publications
2
44
0
Order By: Relevance
“…Recently, cuprizone-mediated demyelination was shown to be alleviated in mice lacking microglial SIRPα that have increased numbers of CD11c+ microglia, pointing to their protective role (89). In line with the induction of CD11c+ microglia (81), stimulation of CSF1R ameliorated cuprizone-induced demyelination (146).…”
Section: Multiple Sclerosismentioning
confidence: 97%
“…Recently, cuprizone-mediated demyelination was shown to be alleviated in mice lacking microglial SIRPα that have increased numbers of CD11c+ microglia, pointing to their protective role (89). In line with the induction of CD11c+ microglia (81), stimulation of CSF1R ameliorated cuprizone-induced demyelination (146).…”
Section: Multiple Sclerosismentioning
confidence: 97%
“…Microglia and CSF1R signaling pathway are involved in different neuroprotective roles, such as clearing myelin debris and toxic proteins from the cerebral environment. In this regard, modulation of the receptor is thought to be a novel therapeutic avenue for diseases, such as Alzheimer's disease (AD), multiple sclerosis (MS), and brain tumors (2,(4)(5)(6)(7). To better understand how CSF1R drives proliferation of microglial cells, we have deleted this receptor specifically in CX3CR1-postive cells in different nerve damage and pathologic models.…”
Section: Introductionmentioning
confidence: 99%
“…One of the first papers providing evidence that increased recruitment of microglia/macrophages can support remyelination, regarded the anti-fungal amphotericin B and its association with macrophage colony-stimulating factor (M-CSF). Although using amphotericin B is precluded by its ability to stimulate TNF secretion and its toxic properties (Doring et al, 2015), the increased uptake of myelin debris induced by M-CSF in the cuprizone model remains interesting (Laflamme et al, 2018). The adoptive transfer of bone-marrow-derived M2 macrophages results in a shift of the immunological response from helper T1 to helper T2 lymphocytes through the production of anti-inflammatory cytokines, which in turn induces the polarization of microglia/macrophages to the M2 phenotype in a model of spinal cord injury (Ma et al, 2015).…”
Section: Therapeutic Modulation Of Microglia/macrophagesmentioning
confidence: 99%